<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000511.v1.p1" parentStudy="phs000511.v1.p1" createDate="2012-07-06" modDate="2012-10-02">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>E.S.G.Stroes, Prof. Dr</td><td>AMC, University of Amsterdam, Amsterdam, The Netherlands</td></tr>
		<tr><td>Principal Investigator</td><td>G.M.Dallinga-Thie, PhD</td><td>AMC, University of Amsterdam, Amsterdam, The Netherlands</td></tr>
		<tr><td>Co-Investigator</td><td>Sekar Kathiresan, MD</td><td>Massachusetts General Hospital, Boston, MA, USA</td></tr>
		<tr><td>Funding Source</td><td>U54 HG003067</td><td>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam</StudyNameEntrez>
	<StudyNameReportPage>Treatment of genetic screening of hypertriglyceridemia type I, III, and V - HTG Amsterdam</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Probands</StudyType>
		<StudyType>Mendelian</StudyType>
		<StudyType>Family</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><ul>Inclusion:<li>See Surendran RP et al., <a href="http://www.ncbi.nlm.nih.gov/pubmed/22239554">J Inte Med, 2012</a></li></ul> <ul><li>TG &gt;10 mmol/l</li></ul> </p> <p><ul>Exclusion: <li>ApoE2E2</li></ul> <ul><li>Alcohol abuse</li></ul> <ul><li>Uncontrolled diabetes</li></ul> </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="22239554"/>
		</Publication>
		<Publication>
			<Pubmed pmid="21597005"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20657596"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Hypertriglyceridemia"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>E.S.G.Stroes, Prof. Dr</AttName>
			<Institution>AMC, University of Amsterdam, Amsterdam, The Netherlands</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>G.M.Dallinga-Thie, PhD</AttName>
			<Institution>AMC, University of Amsterdam, Amsterdam, The Netherlands</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Sekar Kathiresan, MD</AttName>
			<Institution>Massachusetts General Hospital, Boston, MA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U54 HG003067</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>This is a cohort collected at the outpatient clinic of the AMC. Patients have been collected in the past 15 years.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HTG" longName="Hypertriglyceridemia type I, III, and V"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000511.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000511.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000511.v1.p1" FileName="Hypertriglyceridemia_DUC.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Hypertriglyceridemia type I, III, and V</ConsentName>
        <ConsentAbbrev>HTG</ConsentAbbrev>
        <UseLimitation>Cardiovascular disease and hypertriglyceridemia</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
